Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Control Release. 2022 Jan 22;343:267–276. doi: 10.1016/j.jconrel.2022.01.024

Figure 2: Antitumor efficacy of 131I-ELP in orthotopic 4T1 tumors.

Figure 2:

(A) Average size of untreated tumors or tumors treated with 122.1 kBq/mm3, 244.2 kBq/mm3, and 370 kBq/mm3 of 131I-ELP through first 19 days post-treatment (n=4). (B) Kaplan-Meier survival curves for treatment groups. (n=4). *p<0.05 (ANOVA, Tukey).